001     300604
005     20250423112815.0
024 7 _ |a 10.1016/j.diabres.2025.112187
|2 doi
024 7 _ |a pmid:40252778
|2 pmid
024 7 _ |a 0168-8227
|2 ISSN
024 7 _ |a 1872-8227
|2 ISSN
037 _ _ |a DKFZ-2025-00818
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Chen, Zehui
|0 P:(DE-He78)3fdaf0e9a50d16dd82e91a1552dd13e9
|b 0
|e First author
|u dkfz
245 _ _ |a Family history of diabetes mellitus and risk of colorectal cancer: A nationwide cohort study.
260 _ _ |a Amsterdam [u.a.]
|c 2025
|b Elsevier Science
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1745330025_26883
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:C120#LA:C120#
520 _ _ |a Studies have shown the association between personal history of diabetes mellitus (DM type 1/2) and risk of colorectal cancer (CRC). This study aims to find the association between the family history of diabetes and CRC risk.This large nationwide cohort study leveraged data from several Swedish nationwide registers (follow-up: 1964-2018) to compare the risk using standardized incidence ratio (SIR).11,784,567 individuals (668,348 with DM) were included and followed for up to 54 years (median = 28 years). Those with a personal history of DM had a 1.4-fold increased risk of CRC compared to those without DM (95 % CI: 1.39-1.45). However, the addition of a family history of DM in 1 FDR or ≥ 2 FDRs did not significantly alter the increased risk of early-onset or late-onset CRC.Leveraging one of the world's largest family-disease datasets, our cohort study confirmed that personal history of diabetes is associated with an increased risk of colorectal cancer, but we did not find an association between a family history of diabetes and risk of colorectal cancer.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Cohort study
|2 Other
650 _ 7 |a Colorectal cancer
|2 Other
650 _ 7 |a Family history of diabetes
|2 Other
650 _ 7 |a Nationwide data
|2 Other
700 1 _ |a Kharazmi, Elham
|b 1
700 1 _ |a Liang, Qunfeng
|0 P:(DE-He78)59bc83ea3f8c2a5ef6118233f87b5e68
|b 2
|u dkfz
700 1 _ |a Sundquist, Kristina
|b 3
700 1 _ |a Sundquist, Jan
|b 4
700 1 _ |a Fallah, Mahdi
|0 P:(DE-He78)b510b884502b619724039bf33fdae68a
|b 5
|e Last author
|u dkfz
773 _ _ |a 10.1016/j.diabres.2025.112187
|g Vol. 224, p. 112187 -
|0 PERI:(DE-600)2004910-9
|p 112187
|t Diabetes research and clinical practice
|v 224
|y 2025
|x 0168-8227
909 C O |o oai:inrepo02.dkfz.de:300604
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)3fdaf0e9a50d16dd82e91a1552dd13e9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)59bc83ea3f8c2a5ef6118233f87b5e68
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)b510b884502b619724039bf33fdae68a
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2025
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2024-12-10
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b DIABETES RES CLIN PR : 2022
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-10
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-10
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-10
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b DIABETES RES CLIN PR : 2022
|d 2024-12-10
920 2 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Primäre Krebsprävention
|x 0
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Primäre Krebsprävention
|x 0
920 0 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Primäre Krebsprävention
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21